Intensified MR-guided pulsed adaptive cancer treatment- a potential new treatment option for large(>5cm) central non-small cell lung cancer, a case report - Summary - MDSpire
Advertisement
Intensified MR-guided pulsed adaptive cancer treatment- a potential new treatment option for large(>5cm) central non-small cell lung cancer, a case report
To explore the effectiveness of MR-guided adaptive radiotherapy in treating large, inoperable, centrally located non-small cell lung cancer (NSCLC) with poor response to immunotherapy.
Key Findings:
Significant tumor regression was observed, with size reduction from 55 mm to 17 mm and metabolic activity decrease (SUVmax from 33.1 to 5.13) after treatment.
No acute or late toxicity was reported during the treatment process.
Comparative imaging showed less extensive post-radiation lung changes than typically observed after conventional radiotherapy.
Interpretation:
Limitations:
The findings are based on a single case study, limiting generalizability.
Further clinical trials are needed to confirm the benefits in larger patient populations.
